Literature DB >> 6296002

Ceftizoxime in the treatment of infections in patients with cancer.

V Fainstein, R Bolivar, L Elting, M Valdivieso, G P Bodey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6296002     DOI： 10.1093/jac/10.suppl_c.167

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

Review 1.  A retrospective analysis of pharmacokinetic-pharmacodynamic parameters as indicators of the clinical efficacy of ceftizoxime.

Authors:  A Sánchez-Navarro; C I Colino; M M Sánchez Recio
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Ceftriaxone versus aztreonam plus cefazolin for infections in cancer patients with adequate neutrophil counts.

Authors:  F Menichetti; A Del Favero; G Bucaneve; V Minotti; L Patoia; S Pauluzzi
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

Review 3.  Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R C Heel
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.